Bausch + Lomb Corp

Bausch + Lomb Corporation (NYSE/TSX: BLCO) is a global eye health company with a nearly two-century history, offering a comprehensive portfolio of products spanning contact lenses (including daily silicone hydrogel and ULTRA lines), consumer eye care (including the LUMIFY redness reliever and Artelac brands), prescription ophthalmic pharmaceuticals (including MIEBO for dry eye disease), and surgical devices and equipment (including premium intraocular lenses). The company operates through three segments: Vision Care, Surgical, and Pharmaceuticals, serving patients and eye care professionals worldwide. Bausch + Lomb is currently a majority-owned subsidiary of Bausch Health Companies Inc. (BHC), with a proposed separation into a fully independent publicly traded entity still under consideration, subject to regulatory and shareholder approvals and targeted debt leverage ratios. The company's pipeline includes several potential first-in-class assets across ophthalmic therapeutic categories. Updated Oct 28, 2026